Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (225)	2/7/2000 10:36:00 PM
From: Michael Young	Read Replies (1) \| Respond to of 1142

<<After reading a lot of the analysts comments on some shares and seeing what the market has done to some shares historically, I'm a little hesitant to listen too closely to the market.>> Ignore the market at your peril. Don't spent too much time reading analyst reports. Don't forget that MSFT and DELL looked "expensive" a decade ago. Whatever happened to Commodore and Borland? They were "cheapies" then. MIKE

To: Torben Noerup Nielsen who wrote (225)	2/7/2000 10:57:00 PM
From: Arthur Radley	Read Replies (3) \| Respond to of 1142

Jack, I will look forward to reading the Worth article. All of my magazines go to my post office address and since I haven't had the opportunity to get my mail for the past few days, I will make sure that I go tomorrow. As for Genentech, a good friend who is a co-founder of the largest oncology management company told me about IMNX when was around $35...and like Genentech, I didn't buy IMNX, even though he had great hopes for their drugs with their patients.(:<<<<)